| 5FU & Folinic Acid Chemotherapy: de Gramont and modified de Gramont and Fluorouracil (5FU)
|
| Abiraterone Protocol
|
| Abraxane
|
| ACE + IT MTx: Cyclophosphamide, Dactinomycin (Cosmegen Lyovac®), Etoposide (VP-16, Etopophos®, Vepesid®) and Methotrexate
|
| Afatanib
|
| BEP
|
| Bevacizumab
|
| Cabazitaxel
|
| Cabozantinib (cabometyx)
|
| Caelyx (liposomal Doxorubicin)
|
| Capecitabine
|
| Capecitabine (Xeloda®)
|
| Carboplatin and Etoposide Chemotherapy
|
| Carboplatin and vinorelbine
|
| Carboplatin Chemotherapy
|
| CAV
|
| Cetuximab
|
| Cisplatin / Etoposide
|
| Cisplatin and 5FU Chemotherapy
|
| Cisplatin and Etoposide Chemotherapy: Cisplatin and Etoposide® (VP-16, Etopophos, Vepesid®)
|
| Cisplatin and Gemcitabine Chemotherapy: Cisplatin and Gemcitabine (Gemzar®)
|
| Cisplatin and Vinorelbine
|
| Cisplatin Chemotherapy
|
| Cisplatin Gemcitabine
|
| Cisplatin and Doxorubicin
|
| Controlling Nausea & Vomiting: Anti Emetic Therapy Advice V3.1
|
| Cyclophosphamide
|
| Dacarbazine (DTIC)
|
| Degaralyx
|
| Denosumab
|
| Docetaxel (Taxotere®) Chemotherapy
|
| Docetaxel and carboplatin
|
| Docetaxel and cyclophosphamide (TC)
|
| Doxorubicin
|
| Doxorubicin and Cyclophosphamide (AC) Chemotherapy
|
| EC
|
| ECF
|
| Enzalutamide
|
| EOF: Epirubicin (Pharmorubicin®), Fluorouracil (5FU) and Oxaliplatin (Eloxatin®)
|
| EOX
|
| Epirubicin Chemotherapy
|
| Epirubicin cisplatin & capecitabine (ECX gastric)
|
| Eribulin
|
| Erlotinib (Tarceva®)
|
| Etposide (IV and oral)
|
| Everolimus in renal cell cancer protocol
|
| FOLFIRI protocol
|
| FOLFIRINOX
|
| FOLFOX protocol
|
| Folinic acid
|
| Fulvestrant
|
| Gemcitabine and Carboplatin Chemotherapy
|
| Gemcitabine Capecitabine
|
| Gemcitabine Chemotherapy
|
| Herceptin/Traztuzumab
|
| Ifos & Adria: Doxorubicin and Ifosfamide (Mitoxana®)
|
| Ifos & Mesna: Ifosfamide (Mitoxana®) and Mesna (Uromitexan®)
|
| Imatininib
|
| Intrathecal Chemotherapy V4.0
|
| Ipilimumab
|
| Irinotecan Chemotherapy
|
| IVA: Dactinomycin (Cosmegen Lyovac®), Ifosfamide (Mitoxana®), Mesna (Uromitexan®) and Vincristine (Oncovin®)
|
| IVAD: Dactinomycin (Cosmegen Lyovac®), Doxorubicin, Ifosfamide (Mitoxana®), Mesna (Uromitexan®) and Vincristine (Oncovin®)
|
| IVADo (maintenance therapy leaflets - note: must also give the four leaflets that make up IVAD. Cyclophosphamide and Vinorelbine (Navelbine®)
|
| Lomustine
|
| MdG - de Gramont and modified de Gramont
|
| Methotrexate
|
| Mitomycin C
|
| Mitomycin C & Fluorouracil
|
| Mitoxantrone
|
| Nintendanib
|
| Nivolumab
|
| Oxaliplatin Chemotherapy
|
| Paclitaxel (Taxol®) and Carboplatin Chemotherapy
|
| Paclitaxel (Taxol®) Chemotherapy
|
| Palbociclib
|
| Panitunimab
|
| Pazopanib
|
| PCV
|
| Pemetrexed
|
| Pemetrexid & Cisplatin
|
| POMB: Bleomycin, Cisplatin, Methotrexate and Vincristine (Oncovin®)
|
| Procarbazine
|
| Sorafenib (Nexavar®)
|
| Sunitinib (Sutent®)
|
| Taxol & Cisplatin: Cisplatin and Paclitaxel (Taxol®)
|
| Taxotere & Capecitabine: Capecitabine (Xeloda®) and Docetaxel (Taxotere®)
|
| Temozolomide (Temodal®)
|
| Temsirolimus
|
| TIP
|
| Topotecan
|
| Trabectedin (Yondelis®)
|
| Trastuzumab
|
| Trastuzumab and Pertuzumab and Docetaxel
|
| Trastuzumab Cisplatin & Capecitabine (HCX gastric)
|
| Triptorelin
|
| VAC: Cyclophosphamide, Dactinomycin (Cosmegen Lyovac®) and Mesna (Uromitexan®)
|
| VACA: Cyclophosphamide, Dactinomycin (Cosmegen Lyovac®), Doxorubicin, Mesna (Uromitexan®), Vincristine (Oncovin®) and Vinblastine (Velbe®)
|
| Vemurafenib
|
| VIA: Dactinomycin (Cosmegen Lyovac®), Ifosfamide (Mitoxana®), Mesna (Uromitexan®) and Vincristine (Oncovin®)
|
| VIDE: Doxorubicin, Etoposide (VP-16, Etopophos®, Vepesid®), Ifosfamide (Mitoxana®), Mesna (Uromitexan®) and Vincristine (Oncovin®)
|
| Vinblastine
|
| Vincristine (Oncovin®)
|
| Vinorelbine (IV and oral)
|
| Vismodegib protocol
|
| Zoledronic acid
|
